A Phase Ii Evaluation of Pemetrexed (Ly231514, Ind #40061) in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
AuthID
P-00V-TB2
P-00V-TB2